• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Signal Transduct Target Ther . Glucosidase alpha neutral C promotes influenza virus replication by inhibiting proteosome-dependent degradation of he

tetano

Editor, Senior Moderator
Signal Transduct Target Ther


. 2025 Apr 23;10(1):131.
doi: 10.1038/s41392-025-02227-6. Glucosidase alpha neutral C promotes influenza virus replication by inhibiting proteosome-dependent degradation of hemagglutinin

Xinzhong Liao[SUP] #[/SUP][SUP] 1 [/SUP], Qian Xie[SUP] #[/SUP][SUP] 1 [/SUP], Minqi Liang[SUP] 1 [/SUP], Qijun Liao[SUP] 1 [/SUP], Bi Huang[SUP] 1 [/SUP], Shengze Zhang[SUP] 1 [/SUP], Feng Zhang[SUP] 1 [/SUP], Liangliang Wang[SUP] 1 [/SUP], Lifang Yuan[SUP] 1 [/SUP], Xuejie Liu[SUP] 1 [/SUP], Simin Wen[SUP] 2 [/SUP], Chuming Luo[SUP] 1 [/SUP], Dayan Wang[SUP] 3 [/SUP], Yongkun Chen[SUP] 4 [/SUP], Huanle Luo[SUP] 5 [/SUP], Yuelong Shu[SUP] 6 7 [/SUP]



Affiliations
Abstract

The H7N9 influenza virus poses a significant threat to human health, and the mechanism by which it infects humans remains incompletely understood. Our investigation has unveiled significant insights into the role of glucosidase alpha, neutral C (GANC) gene in human H7N9 infections. Through whole genome sequencing (WGS), we identified five low-frequency functional and heterozygous variants of GANC strongly associated with human H7N9 infections compared to healthy controls. Furthermore, we observed a reduction in mRNA and protein expression of GANC following H7N9 virus infection in vitro and in vivo. Subsequent experiments involving GANC demonstrated the promotion of H7N9 virus replication in a stable strain with GANC overexpression. Conversely, GANC knockdown exhibited the ability to restrict influenza A virus (IAV) replication, including H7N9, H9N2, and H1N1, both in vitro and in vivo. This inhibition was mediated by GANC's ability to promote the degradation of H7N9 hemagglutinin (HA). Moreover, we discovered that GANC knockdown facilitated the degradation of HA in a proteasome-dependent manner. The inhibition caused by GANC knockdown was mediated by promoting direct binding of HA with the proteasome 26S subunit, non-ATPase, 1 (PSMD1) and PSMD2. All five variants in the GANC gene reduced their ability to promote H7N9 virus replication, and also diminished the levels of GANC-induced HA protein expression. Our findings revealed a novel mechanism by which GANC inhibits the proteasome-dependent degradation of HA to promote H7N9 virus replication. These results suggest that GANC may play an important role in IAV replication.


 
Back
Top